Market Blog » The Arora Report Stock Market News

CONSIDER SHORT SELL $QGLY (QUIGLEY CORP)

June 16, 2009

FDA has ordered $MTXX Matrixx Initiatives to pull several of its zinc based cold remedies from the store shelves. According to FDA, it has received over 100 reports of people loosing sense of smell after using Zicam. QGLY has similar products. Consider sell short QGLY right here at $4.00 and short more if stock goes higher. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number

ADD TO SHORT POSITION ON AMGN AROUND $51.16 AND MORE AS STOCK GOES HIGHER

June 16, 2009

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

CONSIDER SHORT SELL ON $AMGN (AMGEN) AND $BBH (BIOTECH HOLDERS)

June 15, 2009

President Obama in his speech before AMA specifically mentioned generic biologics and anemia drugs. We sold short AMGN around $49.90 and BBH around $90.30. Consider adding to the positions based on technicals. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

CONSIDER SHORT SELL ON $AVAV ( AeroVironment )

June 15, 2009

At the Paris Airshow $BA (Boeing) announced that it is getting into the unmanned aircraft business. This is a major change and will adversely effect the business of AVAV. Consider scaling a short sell on AVAV.Please be aware of the high short interest and periodic short squeezes in the name. Consider using this information to add to the position on both up and down moves www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in

BUY TO COVER VMC (VLCAN MATERIALS)

June 11, 2009

Vulcan Materials announces pricing of public equity offering at $41.00 after the close today. We suggest buy to cover around $41 www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

TEST

June 11, 2009

ADD TO SHORT SELL ON COAL STOCKS

June 11, 2009

Earlier we started lightly scaling in on short sell on coal stocks. Our fundamental checks continue to support our position, although momentum is against us. Consider continue to scale in on spikes in BTU and CNX www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

VINDICATION ON ARST (ARCSIGHT). OUR PREDICTION HAS PROVEN CORRECT

June 11, 2009

On March 08, 2009, we gave a buy signal on ARST at $11. On June 02, 2009, we gave a sell signal at $17.05 for over 50% gain in a short time. We received several emails questioning our methodology by brokers apparently very knowledgeable about this stock. Today after the close, ArcSight sees Q1 EPS 3c-8c vs. consensus 9c and sees Q1 revenue $31M-$34M vs. consensus $34.29M. The stock is down to $15. Once again , our metodolgy made the correct prediction and sold ARST near the high. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD